Purpose. To investigate the yield of core biopsy in the histologic characterization of atypical ductal hyperplasia (ADH) and to assess the radiological patterns, if any, of this condition. Material and methods. January 1993 to October 1997 we studied 553 lesions, 8 of them with a diagnosis of ADH made on microhistologic samples obtained with 14G needles. Biopsy was performed under US guidance in 81.7% of cases and under mammographic guidance in 18.3%. The breast lesions were studied with mammography, US and MRI, the latter in one case. ADH was diagnosed by strict application of Page's and lesion extent criteria. Results. Seven of 8 lesions with a core biopsy diagnosis of ADH were submitted to surgical biopsy. The diagnosis was changed in as...
ABSTRACT: OBJECTIVE. The purpose of our study was to establish whether it might be safe for women wi...
The incidence of malignancy in excision biopsies performed for atypical ductal hyperplasia (ADH) dia...
Abstract Objective: To determine the rates of diagnostic underestimation at stereotactic percutaneo...
BackgroundWith the introduction of mammography screening, we are more often dealing with the diagnos...
AbstractBackgroundWith the introduction of mammography screening, we are more often dealing with the...
OBJECTIVE: The purpose of this study was to evaluate the surgical outcome of atypical ductal hyperpl...
OBJECTIVE. This review was undertaken to determine the reliability of the histologic diagnosis of at...
Objective: To evaluate breast cancer underestimation rate of atypical ductal hyperplasia (ADH) diagn...
Among lesions with uncertain malignant potential found at percutaneous breast biopsy, atypical ducta...
INTRODUCTION: Due to the possibility of underestimation, surgical excision is usually offered to pa...
Abstract Background Percutaneous core needle biopsy (CNB) is considered to be the standard technique...
The incidence of atypia and atypical ductal hyperplasia (ADH) in breast core needle biopsies varies ...
Atypical ductal hyperplasia (ADH) diagnosed by core needle biopsy (CNB) is regarded as an indication...
Purpose: The purpose of this study was to compare the underestimation rate of atypical ductal hyperp...
A b s t r a c t In 824 patients who underwent directional vacuum-assisted biopsies (DVABs) of breast...
ABSTRACT: OBJECTIVE. The purpose of our study was to establish whether it might be safe for women wi...
The incidence of malignancy in excision biopsies performed for atypical ductal hyperplasia (ADH) dia...
Abstract Objective: To determine the rates of diagnostic underestimation at stereotactic percutaneo...
BackgroundWith the introduction of mammography screening, we are more often dealing with the diagnos...
AbstractBackgroundWith the introduction of mammography screening, we are more often dealing with the...
OBJECTIVE: The purpose of this study was to evaluate the surgical outcome of atypical ductal hyperpl...
OBJECTIVE. This review was undertaken to determine the reliability of the histologic diagnosis of at...
Objective: To evaluate breast cancer underestimation rate of atypical ductal hyperplasia (ADH) diagn...
Among lesions with uncertain malignant potential found at percutaneous breast biopsy, atypical ducta...
INTRODUCTION: Due to the possibility of underestimation, surgical excision is usually offered to pa...
Abstract Background Percutaneous core needle biopsy (CNB) is considered to be the standard technique...
The incidence of atypia and atypical ductal hyperplasia (ADH) in breast core needle biopsies varies ...
Atypical ductal hyperplasia (ADH) diagnosed by core needle biopsy (CNB) is regarded as an indication...
Purpose: The purpose of this study was to compare the underestimation rate of atypical ductal hyperp...
A b s t r a c t In 824 patients who underwent directional vacuum-assisted biopsies (DVABs) of breast...
ABSTRACT: OBJECTIVE. The purpose of our study was to establish whether it might be safe for women wi...
The incidence of malignancy in excision biopsies performed for atypical ductal hyperplasia (ADH) dia...
Abstract Objective: To determine the rates of diagnostic underestimation at stereotactic percutaneo...